Heart valve disease (HVD) is the most common cardiac manifestation in the antiphospholipid syndrome (APS). Valve lesions should be described according to the established definition. HVD is progressive despite anticoagulant/antiplatelet treatments. Around 4–6% of patients with HVD in APS will require valve replacement surgery, which is considered a very high risk procedure in APS. Unfortunately, no recommendations regarding medical treatment of antiphospholipid antibodies-associated HVD can be made at this moment. There are evidence-based data and strong pathophysiologic rationale for considering HVD as a manifestation of APS. Thus, HVD should be included as a criterion of definite APS.
HughesGRVHarrisENGharaviAE. The anticardiolipin syndrome. J Rheumatol1986; 13: 486–489.
2.
MiyakisSLockshinMDAtsumiT. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost2006; 4: 295–306.
3.
Espinola-ZavaletaNVargas-BarrónJColmenaresT. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J1999; 137: 974–979.
4.
ZuilySRegnaultVSelton-SutyC. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: Meta-analysis of echocardiographic studies. Circulation2011; 124: 215–224.
5.
AmigoMCGarcía-TorresR. Morphology of vascular, renal and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis. Curr Rheumatol Rep2000; 2: 262–270.
6.
Pardos-GeaJOrdi-RosJAveglianoG. Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients. Lupus2010; 19: 575–582.
7.
KampolisCTektonidouMMoyssakisI. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: A 10-year follow-up study. Semin Arthritis Rheum2014; 43: 558–565.
8.
LockshinMTenediosFPetriM. Cardiac disease in the antiphospholipid syndrome: Recommendations for treatment. Committee consensus report. Lupus2003; 12: 518–523.
9.
ErdozainJGRuiz-IrastorzaGSeguraMI. Cardiac valve replacement in patients with antiphospholipid syndrome. Arthritis Care Res2012; 64: 1256–1260.
10.
WeissSNyzioJBCinesD. Antiphospholipid syndrome: Intraoperative and postoperative anticoagulation in cardiac surgery. J Cardiothorac Vasc Anesth2008; 22: 736–739.
